Prescription drug · NDA
Dextrose in Lactated Ringers NDC 0264-7751
Dextrose monohydrate 5 g/100mL + 4 more ingredients · Injection, Solution · Intravenous · B. Braun Medical Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0264-7751-00 | 00264775100 | 12 CONTAINER in 1 CASE (0264-7751-00) / 1000 mL in 1 CONTAINERMarketed from Feb 24, 1988 | |
| 0264-7751-10 | 00264775110 | 24 CONTAINER in 1 CASE (0264-7751-10) / 500 mL in 1 CONTAINERMarketed from Feb 24, 1988 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dextrose in Lactated Ringers
- Generic name (nonproprietary)
- dextrose, sodium chloride, sodium lactate, potassium chloride, and calcium chloride
- Active ingredients
- Dextrose monohydrate — 5 g/100mLSodium chloride — .6 g/100mLSodium lactate — .31 g/100mLPotassium chloride — .03 g/100mLCalcium chloride — .02 g/100mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- B. Braun Medical Inc.
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 019634
- Marketing start
- Listing expires
- Other FDA classes
- Acidifying Activity (Mechanism)Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)
- Identifiers
- Product ID 0264-7751_4f376c70-2c24-47cb-9e36-dd4671ea2521SPL ID 4f376c70-2c24-47cb-9e36-dd4671ea2521SPL set ID 190da07e-a616-46e6-b4e5-1c0ba39306e5RxCUI 847627UNII LX22YL083G, 451W47IQ8X, TU7HW0W0QT, 660YQ98I10, M4I0D6VV5M
- Pharmacologic class
- Blood Coagulation Factor; Osmotic Laxative; Phosphate Binder; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N400264775100followed by a unit qualifier and the quantityPackage 00264-7751-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Lactated Ringer’s and Dextrose (5%) Injection is indicated for use as a source of water, electrolytes, and calories or as an alkalinizing agent in adults and pediatric patients. Lactated Ringer’s and Dextrose (5%) Injection is indicated for use as a source of water, electrolytes, and calories or as an alkalinizing agent in adults and pediatric patients.
Excerpt only. Read the full label for complete information.